357 related articles for article (PubMed ID: 33205932)
1. [Parkinsonism-associated speech disorders].
Skripkina NA; Arefyeva AP
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10. Vyp. 2):61-66. PubMed ID: 33205932
[TBL] [Abstract][Full Text] [Related]
2. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
3. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P.
Miller N; Nath U; Noble E; Burn D
Neurodegener Dis Manag; 2017 Jun; 7(3):191-203. PubMed ID: 28632098
[TBL] [Abstract][Full Text] [Related]
4. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
Kowalska-Taczanowska R; Friedman A; Koziorowski D
Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of parkinsonian syndromes according to differences in executive functions.
Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
[TBL] [Abstract][Full Text] [Related]
8. Dysarthria enhancement mechanism under external clear speech instruction in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Skrabal D; Tykalova T; Klempir J; Ruzicka E; Rusz J
J Neural Transm (Vienna); 2020 Jun; 127(6):905-914. PubMed ID: 32193733
[TBL] [Abstract][Full Text] [Related]
9. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
[TBL] [Abstract][Full Text] [Related]
10. Instability of syllable repetition in progressive supranuclear palsy.
Skodda S; Grönheit W; Schlegel U
J Neural Transm (Vienna); 2012 Apr; 119(4):457-62. PubMed ID: 22065210
[TBL] [Abstract][Full Text] [Related]
11. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
12. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
Djurić-Jovičić M; Petrović I; Ječmenica-Lukić M; Radovanović S; Dragašević-Mišković N; Belić M; Miler-Jerković V; Popović MB; Kostić VS
J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
[TBL] [Abstract][Full Text] [Related]
13. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Tykalova T; Rusz J; Klempir J; Cmejla R; Ruzicka E
Brain Lang; 2017 Feb; 165():1-9. PubMed ID: 27894006
[TBL] [Abstract][Full Text] [Related]
15. Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson's disease.
Sung YH; Kang SY
Neurol Sci; 2022 Aug; 43(8):4797-4802. PubMed ID: 35347528
[TBL] [Abstract][Full Text] [Related]
16. Acoustical analysis of speech in progressive supranuclear palsy.
Skodda S; Visser W; Schlegel U
J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
[TBL] [Abstract][Full Text] [Related]
17. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
Williams DR; Lees AJ
Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
[TBL] [Abstract][Full Text] [Related]
19. Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis.
Del Prete E; Tommasini L; Mazzucchi S; Frosini D; Palermo G; Morganti R; Pagni C; Tognoni G; Bonuccelli U; Ceravolo R
Neurol Sci; 2021 Apr; 42(4):1483-1490. PubMed ID: 32851538
[TBL] [Abstract][Full Text] [Related]
20. Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes.
Stamelou M; Christ H; Reuss A; Oertel W; Höglinger G
Mov Disord; 2011 Apr; 26(5):901-5. PubMed ID: 21384428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
